Fibrillarin (FBL) Peptide
FBL
Reactivité: Mammifères
Hôte: Synthetic
BP, IHC, WB
N° du produit ABIN938665
Aperçu rapide pour Fibrillarin (FBL) Peptide (ABIN938665)
Antigène
Fibrillarin (FBL)
Origine
Mammifères
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Type de proteíne
- Synthetic
-
Séquence
- GGGFHSGGNR GRGRGGKRGN QSGKNVMVEP HRHEGVFICR GKEDALVTKN
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of FBL antibody,
Alternative Names: Fibrillarin control peptide, Fibrillarin antibody Blocking Peptide, Anti-Fibrillarin Blocking Peptide, FBL Blocking Peptide, Nop1p Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- Fibrillarin (FBL)
-
Sujet
- FBL is a component of a nucleolar small nuclear ribonucleoprotein (snRNP) particle thought to participate in the first step in processing preribosomal RNA. It is associated with the U3, U8, and U13 small nuclear RNAs and is located in the dense fibrillar component (DFC) of the nucleolus. FBL contains an N-terminal repetitive domain that is rich in glycine and arginine residues, like fibrillarins in other species. Its central region resembles an RNA-binding domain and contains an RNP consensus sequence. Antisera from approximately 8 % of humans with the autoimmune disease scleroderma recognise fibrillarin.
-
Poids moléculaire
- 35 kDa
Antigène
-
Vous êtes ici:
